228 related articles for article (PubMed ID: 7697605)
1. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR.
Schwartz S; Caceres C; Morote J; De Torres I; Rodriguez-Vallejo JM; Gonzalez J; Reventos J
Int J Cancer; 1998 May; 76(4):464-7. PubMed ID: 9590118
[TBL] [Abstract][Full Text] [Related]
3. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
[TBL] [Abstract][Full Text] [Related]
4. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
5. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.
Hruza C; Dobianer K; Beck A; Czerwenka K; Hanak H; Klein M; Leodolter S; Medl M; Müllauer-Ertl S; Preiser J
Eur J Cancer; 1993; 29A(11):1593-7. PubMed ID: 8105839
[TBL] [Abstract][Full Text] [Related]
6. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.
Medl M; Sevelda P; Czerwenka K; Dobianer K; Hanak H; Hruza C; Klein M; Leodolter S; Müllauer-Ertl S; Rosen A
Gynecol Oncol; 1995 Dec; 59(3):321-6. PubMed ID: 8522248
[TBL] [Abstract][Full Text] [Related]
7. Amplification and expression of the c-erbB-2 oncogene in normal, hyperplastic, and malignant endometria.
Czerwenka K; Lu Y; Heuss F
Int J Gynecol Pathol; 1995 Apr; 14(2):98-106. PubMed ID: 8601533
[TBL] [Abstract][Full Text] [Related]
8. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T
Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622
[TBL] [Abstract][Full Text] [Related]
9. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template.
Sestini R; Orlando C; Zentilin L; Lami D; Gelmini S; Pinzani P; Giacca M; Pazzagli M
Clin Chem; 1995 Jun; 41(6 Pt 1):826-32. PubMed ID: 7768000
[TBL] [Abstract][Full Text] [Related]
10. Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours.
Schmitt JF; Susil BJ; Hearn MT
Growth Factors; 1996; 13(1-2):19-35. PubMed ID: 8962718
[TBL] [Abstract][Full Text] [Related]
11. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
[TBL] [Abstract][Full Text] [Related]
12. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction.
An HX; Niederacher D; Dominik SI; Kuschel B; Yan H; Dall P; Schnürch HG; Bender HG; Beckmann MW
Anticancer Res; 1997; 17(4B):3133-6. PubMed ID: 9329619
[TBL] [Abstract][Full Text] [Related]
13. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
14. Gene amplifications in advanced-stage human prostate cancer.
Fournier G; Latil A; Amet Y; Abalain JH; Volant A; Mangin P; Floch HH; Lidereau R
Urol Res; 1995; 22(6):343-7. PubMed ID: 7740653
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
[TBL] [Abstract][Full Text] [Related]
16. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas.
al-Kasspooles M; Moore JH; Orringer MB; Beer DG
Int J Cancer; 1993 May; 54(2):213-9. PubMed ID: 8098013
[TBL] [Abstract][Full Text] [Related]
17. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity for amplified genes in human breast carcinoma.
Lönn U; Lönn S; Nilsson B; Stenkvist B
Int J Cancer; 1994 Jul; 58(1):40-5. PubMed ID: 7912234
[TBL] [Abstract][Full Text] [Related]
20. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]